Countries all over the world have begun the process of reopening amidst the COVID-19 pandemic. The first few months this year saw complete lock-down in several countries bringing normal life to a halt and putting a huge negative impact on the global economy. Even as steps are being taken to restore normal economic activities with new social norms, those in the Life Sciences industry are aware of the work that still needs to be done.
While developing a vaccine by Pharma companies is just one part of the huge task ahead, readying the other industries as they try to get their workforce back to work also requires effective guidelines. As COVID-19 continues to spread, many industries are finding themselves scrambling to do what they can to assist in protective measures like PPE shortages.
Michigan-based EMMA International Consulting Group (EMMA International) believes that it is their role and responsibility during this time to continue to be a trusted resource to assist companies in navigating these uncharted waters. The company does this by leveraging its deeply rooted expertise and relationships.
In March of this year, EMMA International was selected to serve on the Oakland County, Michigan “Saving Business, Saving Lives” grant review panel as the expert in FDA compliance. This funding helped companies either scale up production or pivot to produce PPEs. To date, this grant has awarded $519,000 with $1 million in funding approved by The Oakland County Board of Commissioners and County Executive, David Coulter.
About the Company
Over the years, EMMA International has emerged as a global leader in FDA consulting services. It focuses on quality, regulatory, and compliance services for the Biotechnology, Pharmaceuticals, and Medical Device industries. It provides specialized services to satisfy all quality and compliance needs, which are backed by extensive knowledge and industry experience.
EMMA International is certified as a Women’s Business Enterprise (WBE) through the Women’s Business Enterprise National Council (WBENC). It is also ISO 9001:2015 certified for its quality management system. Apart from a wide reach and capability in FDA compliance, the company’s core competency lies in its ability to develop and implement integrated Quality Management Systems (QMS) that conform to a multitude of international regulatory requirements and/or ISO standards. As FDA regulations become more stringent, EMMA International strives to serve companies across the globe by helping them develop an individualized plan to mitigate major challenges in implementing QMS processes.
The two co-founders of EMMA International wanted to create a company that provided a true management consulting experience for the Life Sciences industry.
Kira Jabri, MPH, MSW is a co-founder and serves as EMMA International’s CEO. Mrs. Jabri has over sixteen years of experience as a healthcare professional culminating extensive experience and knowledge of FDA regulated industries. She is responsible for overseeing EMMA International’s ongoing operations, strategy, and development.
Mrs. Jabri serves on the advisory board of Medical Main Street and also on the Membership and Diversity Network committees of MichBio. Additionally, she is one of the founders of the Michigan Medical Device Innovation Forum (MMDIF), which focuses on connecting medical device professionals, entrepreneurs, and manufacturers to discuss some of the current challenges and opportunities to advance the medical device sector in Michigan.
Dr. Carmine Jabri, PhD, MSJ, MSQM, MHA, the other co-founder, serves as EMMA International’s President. Dr. Jabri is an experienced Healthcare and Quality Assurance professional with more than twenty years of experience in implementing, improving, and directing Quality Management Systems and Healthcare Operations. His career includes expertise in the Pharmaceuticals and Medical Device industries.
Dr. Jabri’s extensive knowledge of regulations and guidelines, coupled with his training and facilitation skills, help him lead the team of EMMA International consultants to help organizations improve their quality management systems, reduce costs, reduce errors, and comply with federal, state, and international standards and regulations. Dr. Jabri is an internationally sought-after quality systems expert.
Striving for the Ultimate Goal
EMMA International anticipates that Artificial Intelligence (AI)/Machine Learning (ML) will play a significant role in the Life Sciences industry. In particular, the medical device industry is on the verge of some amazing technological developments that incorporate AI/ML in their composition.
Going forward, one can expect to see EMMA International become an innovative pioneer in the industry. “We want to become a think tank in the life sciences’ innovative technology space, and further nurture our strategic partnerships and alliances toward shared goals. Ultimately, effecting change on a global level is a goal,” concludes the team.